vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and ASHFORD HOSPITALITY TRUST INC (AHT). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $259.0M, roughly 1.1× ASHFORD HOSPITALITY TRUST INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -26.8%, a 123.1% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -6.0%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -7.7%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Ashford Hospitality Trust Inc is a U.S.-headquartered real estate investment trust focused on upper-upscale full-service hotel properties across key U.S. urban, suburban and resort markets. Its portfolio holds assets under top global hospitality brands, serving business and leisure travelers, with a focus on long-term value growth and stable shareholder returns.
ACAD vs AHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $259.0M |
| Net Profit | $273.6M | $-69.3M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | -2.6% |
| Net Margin | 96.3% | -26.8% |
| Revenue YoY | 9.4% | -6.0% |
| Net Profit YoY | 90.3% | 44.2% |
| EPS (diluted) | $1.61 | $-12.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $259.0M | ||
| Q3 25 | $278.6M | $266.1M | ||
| Q2 25 | $264.6M | $302.0M | ||
| Q1 25 | $244.3M | $277.4M | ||
| Q4 24 | $259.6M | $275.5M | ||
| Q3 24 | $250.4M | $276.6M | ||
| Q2 24 | $242.0M | $316.5M | ||
| Q1 24 | $205.8M | $303.9M |
| Q4 25 | $273.6M | $-69.3M | ||
| Q3 25 | $71.8M | $-60.1M | ||
| Q2 25 | $26.7M | $-30.4M | ||
| Q1 25 | $19.0M | $-20.0M | ||
| Q4 24 | $143.7M | $-124.2M | ||
| Q3 24 | $32.8M | $-57.9M | ||
| Q2 24 | $33.4M | $50.3M | ||
| Q1 24 | $16.6M | $71.6M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | -2.6% | ||
| Q3 25 | 12.8% | 4.6% | ||
| Q2 25 | 12.2% | 16.3% | ||
| Q1 25 | 7.9% | 22.2% | ||
| Q4 24 | 59.1% | -17.8% | ||
| Q3 24 | 12.6% | 7.3% | ||
| Q2 24 | 12.6% | 42.8% | ||
| Q1 24 | 7.4% | 50.2% |
| Q4 25 | 96.3% | -26.8% | ||
| Q3 25 | 25.8% | -22.6% | ||
| Q2 25 | 10.1% | -10.1% | ||
| Q1 25 | 7.8% | -7.2% | ||
| Q4 24 | 55.4% | -45.1% | ||
| Q3 24 | 13.1% | -20.9% | ||
| Q2 24 | 13.8% | 15.9% | ||
| Q1 24 | 8.0% | 23.5% |
| Q4 25 | $1.61 | $-12.85 | ||
| Q3 25 | $0.42 | $-11.35 | ||
| Q2 25 | $0.16 | $-6.88 | ||
| Q1 25 | $0.11 | $-4.91 | ||
| Q4 24 | $0.86 | $-13.64 | ||
| Q3 24 | $0.20 | $-12.39 | ||
| Q2 24 | $0.20 | $2.50 | ||
| Q1 24 | $0.10 | $5.99 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $66.1M |
| Total DebtLower is stronger | — | $2.5B |
| Stockholders' EquityBook value | $1.2B | $-626.4M |
| Total Assets | $1.6B | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $66.1M | ||
| Q3 25 | $258.0M | $81.9M | ||
| Q2 25 | $253.6M | $100.0M | ||
| Q1 25 | $217.7M | $85.8M | ||
| Q4 24 | $319.6M | $112.9M | ||
| Q3 24 | $155.1M | $119.7M | ||
| Q2 24 | $177.1M | $121.8M | ||
| Q1 24 | $204.7M | $111.1M |
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.9B |
| Q4 25 | $1.2B | $-626.4M | ||
| Q3 25 | $917.3M | $-548.7M | ||
| Q2 25 | $822.4M | $-485.5M | ||
| Q1 25 | $765.2M | $-446.1M | ||
| Q4 24 | $732.8M | $-419.2M | ||
| Q3 24 | $577.2M | $-288.4M | ||
| Q2 24 | $516.7M | $-225.9M | ||
| Q1 24 | $464.0M | $-276.8M |
| Q4 25 | $1.6B | $2.8B | ||
| Q3 25 | $1.3B | $3.0B | ||
| Q2 25 | $1.2B | $3.1B | ||
| Q1 25 | $1.1B | $3.1B | ||
| Q4 24 | $1.2B | $3.2B | ||
| Q3 24 | $976.9M | $3.3B | ||
| Q2 24 | $914.1M | $3.3B | ||
| Q1 24 | $855.1M | $3.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-15.7M |
| Free Cash FlowOCF − Capex | — | $-86.8M |
| FCF MarginFCF / Revenue | — | -33.5% |
| Capex IntensityCapex / Revenue | — | 27.5% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-135.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $-15.7M | ||
| Q3 25 | $74.3M | $5.5M | ||
| Q2 25 | $64.0M | $16.3M | ||
| Q1 25 | $20.3M | $-25.0M | ||
| Q4 24 | $40.4M | $-23.6M | ||
| Q3 24 | $63.2M | $795.0K | ||
| Q2 24 | $25.0M | $8.0M | ||
| Q1 24 | $29.1M | $-46.5M |
| Q4 25 | — | $-86.8M | ||
| Q3 25 | $73.9M | $-226.0K | ||
| Q2 25 | — | $-3.6M | ||
| Q1 25 | — | $-44.8M | ||
| Q4 24 | — | $-131.6M | ||
| Q3 24 | $63.2M | $-21.8M | ||
| Q2 24 | — | $-22.9M | ||
| Q1 24 | — | $-80.4M |
| Q4 25 | — | -33.5% | ||
| Q3 25 | 26.5% | -0.1% | ||
| Q2 25 | — | -1.2% | ||
| Q1 25 | — | -16.2% | ||
| Q4 24 | — | -47.8% | ||
| Q3 24 | 25.2% | -7.9% | ||
| Q2 24 | — | -7.2% | ||
| Q1 24 | — | -26.5% |
| Q4 25 | — | 27.5% | ||
| Q3 25 | 0.1% | 2.1% | ||
| Q2 25 | — | 6.6% | ||
| Q1 25 | — | 7.2% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | 0.0% | 8.2% | ||
| Q2 24 | — | 9.8% | ||
| Q1 24 | — | 11.2% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 0.16× | ||
| Q1 24 | 1.76× | -0.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
AHT
| Occupancy | $190.2M | 73% |
| Food And Beverage | $51.8M | 20% |
| Hotel Other | $16.6M | 6% |
